Recombinant Human UbcH2/UBE2H Dominant Negative, CF
Recombinant Human UbcH2/UBE2H Dominant Negative, CF Summary
Product Specifications
Accession # P62256
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
E2-608
| Formulation | Supplied as a solution in HEPES, NaCl, DTT and Glycerol. |
| Shipping | The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: UbcH2/UBE2H
Ubiquitin-conjugating Enzyme H2 (UbcH2), also known as Ubiquitin-conjugating Enzyme E2H (UBE2H), is a member of the Ubiquitin-conjugating (E2) enzyme family (1). UbcH2/UBE2H has a predicted molecular weight of 20.5 kDa. The human protein shares 100% amino acid sequence identity with the mouse and rat orthologs. Human UbcH2/UBE2H is highly expressed in skeletal and cardiac muscle, shows significant expression levels in kidney and placenta, and is expressed at low levels in liver, brain, lung, and spleen (2). TNF-alpha induces UbcH2/UBE2H expression via NF-kappa B, and SCL/Tal1 upregulates the expression of UbcH2/UBE2H during erythroid differentiation (2,3). Pathologically, a single nucleotide polymorphism within UbcH2/UBE2H is associated with autism (4). Furthermore, UbcH2/UBE2H has been reported as a putative oncogene for liver tumorigenesis (5). The active site of this protein was chemically inactivated for use as a negative or competitive control.
- Kaiser, P. et al. (1994) J. Biol. Chem. 269:8797.
- Li, Y.P. et al. (2003) FASEB J. 17:1048.
- Lausen, J. et al. (2010) J. Biol. Chem. 285:5338.
- Vourc'h, P. et al. (2003) Psychiatr. Genet. 13:221.
- Keng, V.W. et al. (2009) Nat. Biotechnol. 27:264.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human UbcH2/UBE2H Dominant Negative, CF
There are currently no reviews for this product. Be the first to review Recombinant Human UbcH2/UBE2H Dominant Negative, CF and earn rewards!
Have you used Recombinant Human UbcH2/UBE2H Dominant Negative, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
